Get the Stockscreener App
72.65
0.62%
0.45
Pre-market:
73.00
0.35
+0.48%
Mirum Pharmaceuticals Inc stock is traded at $72.65, with a volume of 389.71K.
It is up +0.62% in the last 24 hours and down -0.90% over the past month.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
See More
Previous Close:
$72.20
Open:
$71.96
24h Volume:
389.71K
Relative Volume:
0.53
Market Cap:
$3.65B
Revenue:
$379.25M
Net Income/Loss:
$-77.34M
P/E Ratio:
-45.06
EPS:
-1.6122
Net Cash Flow:
$-27.87M
1W Performance:
+3.76%
1M Performance:
-0.90%
6M Performance:
+67.20%
1Y Performance:
+88.90%
1-Day Range:
$71.23
$73.23
1-Week Range:
$68.34
$73.23
52-Week Range:
$36.88
$78.54
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
Name
Mirum Pharmaceuticals Inc
Sector
Industry
Phone
650-667-4085
Address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Compare MIRM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
72.65 | 3.63B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Initiated | TD Cowen | Buy |
| Aug-11-25 | Resumed | Stifel | Buy |
| May-19-25 | Resumed | H.C. Wainwright | Buy |
| Apr-17-24 | Initiated | Stifel | Buy |
| Dec-18-23 | Reiterated | H.C. Wainwright | Buy |
| Nov-20-23 | Resumed | JP Morgan | Overweight |
| Nov-13-23 | Initiated | Morgan Stanley | Overweight |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-17-23 | Resumed | Evercore ISI | Outperform |
| Sep-20-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-01-22 | Initiated | Citigroup | Buy |
| Sep-20-21 | Initiated | JP Morgan | Overweight |
| Aug-07-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-03-20 | Initiated | H.C. Wainwright | Buy |
| Jul-31-20 | Initiated | Piper Sandler | Overweight |
| Jun-25-20 | Initiated | Robert W. Baird | Outperform |
| Aug-12-19 | Initiated | Citigroup | Buy |
| Aug-12-19 | Initiated | Evercore ISI | Outperform |
| Aug-12-19 | Initiated | Guggenheim | Buy |
| Aug-12-19 | Initiated | ROTH Capital | Buy |
| Aug-12-19 | Initiated | Raymond James | Outperform |
View All
Mirum Pharmaceuticals Inc Stock (MIRM) Latest News
Why Mirum Pharmaceuticals Inc. stock remains undervaluedBuy Signal & Weekly Breakout Opportunity Watchlist - newser.com
Will Mirum Pharmaceuticals Inc. see short term momentumWeekly Gains Summary & Weekly Breakout Stock Alerts - newser.com
Is Mirum Pharmaceuticals Inc. stock supported by strong cash flowsSwing Trade & Daily Stock Momentum Reports - newser.com
Why analysts remain bullish on Mirum Pharmaceuticals Inc. stockProfit Target & Daily Oversold Bounce Ideas - newser.com
Is Mirum Pharmaceuticals Inc. stock overvalued by current metricsWatch List & Real-Time Volume Trigger Notifications - newser.com
Published on: 2025-11-01 02:12:11 - newser.com
Mirum Pharmaceuticals Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Investors Aren't Buying Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Revenues - 富途牛牛
What analysts say about Mirum Pharmaceuticals Inc stockMarket Profile Overview & High Return Trading Tips - earlytimes.in
How currency fluctuations impact Mirum Pharmaceuticals Inc. stock2025 Analyst Calls & Free Community Supported Trade Ideas - newser.com
Emerald Mutual Fund Advisers Trust Takes $11.07 Million Position in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
How to use Fibonacci retracement on Mirum Pharmaceuticals Inc.July 2025 Selloffs & AI Driven Price Predictions - newser.com
Published on: 2025-10-31 03:46:47 - newser.com
Using RSI to spot recovery in Mirum Pharmaceuticals Inc.July 2025 Analyst Calls & Fast Entry High Yield Tips - newser.com
Will breakout in Mirum Pharmaceuticals Inc. lead to full recoveryTrade Volume Report & Short-Term High Return Ideas - newser.com
Is it time to cut losses on Mirum Pharmaceuticals Inc.Jobs Report & High Accuracy Swing Entry Alerts - newser.com
How to build a custom watchlist for Mirum Pharmaceuticals Inc.2025 Biggest Moves & AI Driven Stock Reports - newser.com
Published on: 2025-10-31 01:07:37 - newser.com
Published on: 2025-10-30 23:29:10 - newser.com
Emerald Advisers LLC Acquires Shares of 305,766 Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Will Mirum Pharmaceuticals Inc. (08D) stock keep high P E multiplesJuly 2025 Summary & Comprehensive Market Scan Reports - newser.com
Mirum Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
AlphaQuest LLC Sells 12,797 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Published on: 2025-10-29 01:58:20 - newser.com
Published on: 2025-10-29 01:50:33 - newser.com
Mirum Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 - BioSpace
Published on: 2025-10-28 04:35:21 - newser.com
Published on: 2025-10-28 02:45:58 - newser.com
Published on: 2025-10-28 00:12:15 - newser.com
Published on: 2025-10-27 23:28:31 - newser.com
Can Mirum Pharmaceuticals Inc. (08D) stock surprise markets with earningsJuly 2025 Pullbacks & Short-Term High Return Ideas - Fundação Cultural do Pará
Mirum Pharmaceuticals Inc Stock (MIRM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):